iRadimed Corporation
Last updated September 27, 2026
Organization details
- Legal name
- iRadimed Corporation
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 โ Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Orlando
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- IRMD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001325618
- EIN
- 73-1408526
Board of directors
-
Anthony Vuoto ยท DirectorSince 2023
-
Hilda Frederique Scharen-Guivel ยท DirectorSince 2023
-
James B. Hawkins ยท DirectorSince 2023
-
Joe E. Kiani ยท DirectorSince 2025
-
Monty K. Allen ยท DirectorSince 2023
-
Roger E. Susi ยท Director ยท CEO, President, ChairmanSince 2023
Chief executives
Roger E. Susi
ยท President, CEO and Chairman
Dates unknown
Director election results
Annual meeting of June 24, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
77.7%
-
81.4%
-
87.3%
-
98.1%
-
98.9%
Board connections
1 of this board's directors also sit on 2 other boards.
- via James B. Hawkins
- via James B. Hawkins
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $20,692,751
- 129 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Joe E. Kiani Director | Option exercise | +698 | โ | โ |
| Sep 3, 2026 | Monty K. Allen Director | Open-market sale | โ1,014 | $86.44 | $87,650 |
| Sep 3, 2026 | Monty K. Allen Director | Open-market sale | โ405 | $86.35 | $34,972 |
| Jun 20, 2026 | GLENN JOHN Officer (CFO) | Option exercise | +5,796 | โ | โ |
| Jun 20, 2026 | GLENN JOHN Officer (CFO) | Shares withheld for tax | โ2,319 | $92.20 | $213,812 |
| Jun 4, 2026 | Hilda Frederique Scharen-Guivel Director | Open-market sale | โ1,766 | $95.00 | $167,770 |
| Jun 4, 2026 | Hilda Frederique Scharen-Guivel Director | Open-market sale | โ1,234 | $95.00 | $117,230 |
| Jun 1, 2026 | Roger E. Susi Director, Officer (CEO, President, Chairman), 10% owner | Open-market sale | โ400 | $88.68 | $35,472 |
| Jun 1, 2026 | Roger E. Susi Director, Officer (CEO, President, Chairman), 10% owner | Open-market sale | โ775 | $89.79 | $69,587 |
| Jun 1, 2026 | Roger E. Susi Director, Officer (CEO, President, Chairman), 10% owner | Open-market sale | โ401 | $91.08 | $36,523 |
| Jun 1, 2026 | Roger E. Susi Director, Officer (CEO, President, Chairman), 10% owner | Open-market sale | โ924 | $91.91 | $84,925 |
| May 27, 2026 | Roger E. Susi Director, Officer (CEO, President, Chairman), 10% owner | Open-market sale | โ2,167 | $91.85 | $199,039 |
| May 27, 2026 | Roger E. Susi Director, Officer (CEO, President, Chairman), 10% owner | Open-market sale | โ333 | $92.61 | $30,839 |
| May 26, 2026 | Roger E. Susi Director, Officer (CEO, President, Chairman), 10% owner | Open-market sale | โ3,111 | $91.81 | $285,621 |
| May 26, 2026 | Roger E. Susi Director, Officer (CEO, President, Chairman), 10% owner | Open-market sale | โ1,889 | $92.93 | $175,545 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.